Skip to main content
. 2020 Aug 11;108(2):379–389. doi: 10.1016/j.ijrobp.2020.06.054

Fig. 2.

Fig. 2

(A) Curative-intent (including cutaneous) consensus scores: multiple regression lines, each representing a disease group, of the shifts in the quality of evidence from routinely used highest-quality curative-intent schedules to COVID-era schedules. Dotted black line (slope of 1) represents no change in the quality of evidence. Paired t test comparing the regression lines’ slopes to the diagonal slope of 1 was significant (P < .01). Lines are truncated to avoid extrapolation outside of known data points. (B) Site-specific palliative consensus scores: multiple regression lines, each representing a disease group, of the shifts in the quality of evidence from routinely used highest-quality, site-specific palliative schedules to COVID-era schedules. Dotted black line (slope of 1) represents no change in the quality of evidence. Paired t test comparing the regression lines’ slopes to the diagonal slope of 1 showed mixed results (eg, cutaneous had a slope of 1 and CNS had a slope of 0). Lines are truncated to avoid extrapolation outside of known data points. Abbreviations: CNS = central nervous system; GI = gastrointestinal; GU = genitourinary.